Prof Andrew Lonie
Director and Strategic Advisor
Melbourne Bioinformatics (VLSCI)
62 Scholarly works
27 Projects
HIGHLIGHTS
2026
Research contracts (non-grants)
UoM and Baker Collaboration Agreement 2025
2025
Journal article
The Germline and Somatic Origins of Prostate Cancer Heterogeneity
DOI: 10.1158/2159-8290.CD-23-08822023
Research grants (ARC, NHMRC, MRFF)
Building the Australian Cardiovascular Disease Data Commons (ACDC)
2022
Journal article
The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update
DOI: 10.1093/nar/gkac2472021
Journal article
Ready-to-use public infrastructure for global SARS-CoV-2 monitoring
DOI: 10.1038/s41587-021-01069-12017
Research Grant
A High-Performance Cloud Resource for Computational Modelling
2015
Journal article
Whole-genome characterization of chemoresistant ovarian cancer
DOI: 10.1038/nature14410
RECENT SCHOLARLY WORKS
2021
Journal article
Application of a bioinformatics training delivery method for reaching dispersed and distant trainees
DOI: 10.1371/JOURNAL.PCBI.10087152020
Journal article
No more business as usual: Agile and effective responses to emerging pathogen threats require open data and open analytics
DOI: 10.1371/JOURNAL.PPAT.10086432019
Journal article
Sharing interoperable workflow provenance: A review of best practices and their practical application in CWLProv.
DOI: 10.1093/gigascience/giz0952019
Journal article
CloudLaunch: Discover and deploy cloud applications
DOI: 10.1016/j.future.2018.04.0372019
Journal article
Establishing a distributed national research infrastructure providing bioinformatics support to life science researchers in Australia
DOI: 10.1093/bib/bbx0712019
Journal article
Hi-Plex2: A simple and robust approach to targeted sequencing-based genetic screening
DOI: 10.2144/btn-2019-00262018
Journal article
Is RNASEL: P.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations?
DOI: 10.1186/s12885-018-4028-z
RECENT PROJECTS
2021
Research Grant
Extending Galaxy for Large-Scale and Integrative Biomedical Analyses (EOSS3)